DXSE.DE vs. XGEN.DE
DXSE.DE (Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C) and XGEN.DE (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) are both Health & Biotech Equities funds from Xtrackers - DXSE.DE tracks the MSCI Europe Health Care ESG Screened 20-35 while XGEN.DE tracks the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. Both are passively managed. Over the past 3 years, DXSE.DE returned 2.51%/yr vs 1.39%/yr for XGEN.DE. At a 0.48 correlation, their price movements are largely independent. DXSE.DE charges 0.17%/yr vs 0.30%/yr for XGEN.DE.
Performance
DXSE.DE vs. XGEN.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DXSE.DE achieves a -1.95% return, which is significantly lower than XGEN.DE's -1.40% return.
DXSE.DE
- 1D
- 2.90%
- 1M
- 1.98%
- YTD
- -1.95%
- 6M
- -0.40%
- 1Y
- 4.80%
- 3Y*
- 2.51%
- 5Y*
- 5.38%
- 10Y*
- 6.10%
XGEN.DE
- 1D
- 3.92%
- 1M
- 6.45%
- YTD
- -1.40%
- 6M
- -3.78%
- 1Y
- 22.37%
- 3Y*
- 1.39%
- 5Y*
- —
- 10Y*
- —
DXSE.DE vs. XGEN.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
DXSE.DE Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C | -1.95% | 4.97% | 4.52% | 9.56% | -5.83% |
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -1.40% | 7.38% | 2.95% | -5.84% | -9.98% |
Correlation
The correlation between DXSE.DE and XGEN.DE is 0.62, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.62 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.49 |
Correlation (All Time) Calculated using the full available price history since Jul 20, 2022 | 0.48 |
The correlation between DXSE.DE and XGEN.DE shifts across timeframes, from 0.48 (all time) to 0.62 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DXSE.DE vs. XGEN.DE — Risk / Return Rank
DXSE.DE
XGEN.DE
DXSE.DE vs. XGEN.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| DXSE.DE | XGEN.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.96 | ||
| Sortino ratioReturn per unit of downside risk | -1.31 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.21 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 0.38 | 1.49 | -1.11 |
| Martin ratioReturn relative to average drawdown | 0.82 | 3.61 | -2.78 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| DXSE.DE | XGEN.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.27 | 1.23 | -0.96 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.32 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.38 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.45 | -0.11 | +0.55 |
Drawdowns
DXSE.DE vs. XGEN.DE - Drawdown Comparison
The maximum DXSE.DE drawdown since its inception was -34.30%, smaller than the maximum XGEN.DE drawdown of -37.58%. Use the drawdown chart below to compare losses from any high point for DXSE.DE and XGEN.DE.
Loading charts...
Drawdown Indicators
| DXSE.DE | XGEN.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -34.30% | -37.58% | +3.28% |
Max Drawdown (1Y)Largest decline over 1 year | -12.67% | -14.99% | +2.32% |
Max Drawdown (3Y)Largest decline over 3 years | -28.10% | -28.21% | +0.11% |
Max Drawdown (5Y)Largest decline over 5 years | -28.10% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -28.10% | — | — |
Current DrawdownCurrent decline from peak | -13.88% | -14.86% | +0.98% |
Average DrawdownAverage peak-to-trough decline | -8.34% | -19.44% | +11.10% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.81% | 6.19% | -0.38% |
Volatility
DXSE.DE vs. XGEN.DE - Volatility Comparison
The current volatility for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE) is 5.82%, while Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) has a volatility of 6.48%. This indicates that DXSE.DE experiences smaller price fluctuations and is considered to be less risky than XGEN.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DXSE.DE | XGEN.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.82% | 6.48% | -0.66% |
Volatility (6M)Calculated over the trailing 6-month period | 11.95% | 13.73% | -1.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.63% | 18.19% | -0.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.48% | 18.66% | -2.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.04% | 18.66% | -2.62% |
DXSE.DE vs. XGEN.DE - Expense Ratio Comparison
DXSE.DE has a 0.17% expense ratio, which is lower than XGEN.DE's 0.30% expense ratio.
Dividends
DXSE.DE vs. XGEN.DE - Dividend Comparison
Neither DXSE.DE nor XGEN.DE has paid dividends to shareholders.
Frequently Asked Questions
DXSE.DE and XGEN.DE have a correlation of 0.62, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, DXSE.DE is cheaper at 0.17% per year. The better choice depends on whether you care most about return, fees, risk, or income.
DXSE.DE is cheaper with a 0.17% expense ratio, compared with 0.30% for XGEN.DE.
DXSE.DE tracks MSCI Europe Health Care ESG Screened 20-35, while XGEN.DE tracks MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. Their fees differ too: 0.17% for DXSE.DE and 0.30% for XGEN.DE.
Find the right allocation for DXSE.DE and XGEN.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer